Status:
ACTIVE_NOT_RECRUITING
Natural History Study of Retinitis Pigmentosa Type 11
Lead Sponsor:
Oslo University Hospital
Conditions:
Retinitis Pigmentosa 11
Retinitis Pigmentosa
Eligibility:
All Genders
18+ years
Brief Summary
Observational study of patients with retinitis pigmentosa type 11
Detailed Description
Natural history study with clinical examination every 6 months.
Eligibility Criteria
Inclusion
- Clinical diagnosis of retinitis pigmentosa caused by a disease-causing mutation involving the PRPF31 gene
- Or disease-causing mutation involving the PRPF31 gene without the clinical diagnosis of retinitis pigmentosa
Exclusion
- Under 18 years
- Other types of retinitis pigmentosa
Key Trial Info
Start Date :
February 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2028
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04805658
Start Date
February 1 2021
End Date
April 1 2028
Last Update
March 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Ophthalmology, Oslo University Hospital
Oslo, Norway, 0450